Almousa H, Ouachée-Chardin M, Picard C, Radford-Weiss I, Caillat-Zucman S, Cavazzana-Calvo M, Blanche S, de Saint Basile G, Le Deist F, Fischer A
Unité d'Immunologie-Hématologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France.
Br J Haematol. 2005 Aug;130(3):404-8. doi: 10.1111/j.1365-2141.2005.05615.x.
Familial haemophagocytic lymphohistiocytosis (FHLH) is a genetic disorder caused by defective lymphocyte cytotoxicity, resulting in impaired lymphocyte homeostasis and macrophage infiltration of solid tissues and bone marrow, with extensive haemophagocytosis. It is invariably fatal unless treated by allogeneic haematopoietic stem cell transplantation (HSCT). In a retrospective analysis of 11 cases of FHLH, transplanted in one centre between January 1999 and December 2003, it was found that host T cell expansion occurred early after HSCT in a setting of a viral infection (cytomegalovirus and Epstein-Barr virus respectively) in two cases who received T cell-depleted HSCT. Transient recurrence of clinical and biological manifestations of FHLH was observed, despite evidence for donor cell engraftment. Secondary development of donor T cells led to stable mixed chimaerism and sustained remission of FHLH. Detection of host-derived T cells soon after HSCT in a patient with FHLH should thus not mistakenly be taken as a manifestation of graft rejection.
家族性噬血细胞性淋巴组织细胞增生症(FHLH)是一种由淋巴细胞细胞毒性缺陷引起的遗传性疾病,导致淋巴细胞内环境稳定受损,巨噬细胞浸润实体组织和骨髓,并伴有广泛的噬血细胞现象。除非通过异基因造血干细胞移植(HSCT)进行治疗,否则该病必然致命。在对1999年1月至2003年12月期间在一个中心接受移植的11例FHLH患者进行的回顾性分析中,发现接受去除T细胞的HSCT的2例患者在病毒感染(分别为巨细胞病毒和EB病毒)的情况下,HSCT后早期出现宿主T细胞扩增。尽管有供体细胞植入的证据,但仍观察到FHLH的临床和生物学表现短暂复发。供体T细胞的继发发展导致稳定的混合嵌合体形成和FHLH的持续缓解。因此,对于FHLH患者,HSCT后不久检测到宿主来源的T细胞不应错误地视为移植排斥反应的表现。